-
Colorectal cancer is now the most common cause of cancer deaths in the US for people under 50The American Cancer Society estimates that over 55,000 people will die from colorectal cancer in the U.S. this year. Of those, 7% will be under 50.
8 Comments -
Measles' resurgence in the US is a grim sign of what's comingTwo pandemic researchers explore the recent resurgence of measles in the U.S. and what it could mean for the future of disease responsiveness.
-
Single protein could dramatically alter trajectory of Alzheimer's diseaseIn people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.
-
A parasite never before seen in humans was behind a woman's lung infection, organ damage and forgetfulnessA woman developed a persistent infection, and doctors couldn't pinpoint the cause for many months.
6 Comments -
Obesity is linked to 1 in 10 deaths from infection worldwide — and scientists are still learning whyA new study finds that people with obesity are more likely to be hospitalized with or die from severe infections.
-
Diagnostic dilemma: 83-year-old man's unusual form of syphilis had an 'uncertain' sourceA man went to the emergency room after being in and out of hospitals for a month, and doctors found a surprising explanation for his illness.
7 Comments -
Vaccine denial sets Americans up for more chronic illnessOpinion Despite well-established links between pathogens and chronic illness, the U.S. government continues to weaken public health measures to treat and prevent infectious diseases — a strategy that will ultimately make Americans even sicker.
7 CommentsOpinion -
'DNA origami' could be key for making an effective HIV vaccine, early study hintsA new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make protective antibodies against HIV.
-
Cancer vaccine shows promise against HPV-related throat tumors in early studyIf proven effective in humans, the vaccine could complement standard therapies for HPV-driven cancer, as well as inform the design of therapeutic vaccines for other diseases.
